BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19455509)

  • 1. Power and sample size calculations for current status survival analysis.
    Williamson JM; Lin HM; Kim HY
    Stat Med; 2009 Jul; 28(15):1999-2011. PubMed ID: 19455509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Power and sample size calculations for interval-censored survival analysis.
    Kim HY; Williamson JM; Lin HM
    Stat Med; 2016 Apr; 35(8):1390-400. PubMed ID: 26643411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power calculation for a score test in the dependent censoring model.
    Lee SY
    Stat Med; 1996 May; 15(10):1049-58. PubMed ID: 8783441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size calculation for the weighted rank statistics with paired survival data.
    Jung SH
    Stat Med; 2008 Jul; 27(17):3350-65. PubMed ID: 18205148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample-size calculations for studies with correlated ordinal outcomes.
    Kim HY; Williamson JM; Lyles CM
    Stat Med; 2005 Oct; 24(19):2977-87. PubMed ID: 16149125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple approach to power and sample size calculations in logistic regression and Cox regression models.
    Vaeth M; Skovlund E
    Stat Med; 2004 Jun; 23(11):1781-92. PubMed ID: 15160408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size calculations for population pharmacodynamic experiments involving repeated dichotomous observations.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2008; 18(6):1212-27. PubMed ID: 18991118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing phase II studies in cancer with time-to-event endpoints.
    Owzar K; Jung SH
    Clin Trials; 2008; 5(3):209-21. PubMed ID: 18559409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A general approach for sample size and statistical power calculations assessing of interventions using a mixture model in the presence of detection limits.
    Nie L; Chu H; Cole SR
    Contemp Clin Trials; 2006 Oct; 27(5):483-91. PubMed ID: 16769254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size/power calculations for population pharmacodynamic experiments involving repeated-count measurements.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2010 Sep; 20(5):1026-42. PubMed ID: 20721789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
    Mielke M; Munk A; Schacht A
    Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical power and estimation of the number of required subjects for a study based on the t-test: a surgeon's primer.
    Livingston EH; Cassidy L
    J Surg Res; 2005 Jun; 126(2):149-59. PubMed ID: 15919413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robustness of a parametric model for informatively censored bivariate longitudinal data under misspecification of its distributional assumptions: A simulation study.
    Pantazis N; Touloumi G
    Stat Med; 2007 Dec; 26(30):5473-85. PubMed ID: 18058854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal sample size determinations from an industry perspective based on the expected value of information.
    Willan AR
    Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G; Bretz F; Hothorn LA; Guiard V
    Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power and sample size calculations for discrete bounded outcome scores.
    Tsonaka R; Rizopoulos D; Lesaffre E
    Stat Med; 2006 Dec; 25(24):4241-52. PubMed ID: 16947202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size and statistical power assessing the effect of interventions in the context of mixture distributions with detection limits.
    Chu H; Nie L; Cole SR
    Stat Med; 2006 Aug; 25(15):2647-57. PubMed ID: 16456897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling survival data with informative cluster size.
    Williamson JM; Kim HY; Manatunga A; Addiss DG
    Stat Med; 2008 Feb; 27(4):543-55. PubMed ID: 17640035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.